Prescription Analysis

1. IV Fluids (RL, NS, DNS)
2. Inj. Meropenem 1g IV BD
3. Inj. Amikacin 300mg IV BD
4. Inj. Pantoprazole 40mg IV OD
5. Inj. Ondansetron (Zofer) 4mg IV BD
6. Tab. Doxycycline 100mg PO BD
7. Tab. Levocetirizine (Levout) 10mg PO OD
8. Tab. Paracetamol (PCM) 500mg PO TID
9. Syp. Ambroxol (Ambromyl) 10ml PO TID
10. Tab. Albendazole (Zentel) 400mg PO BD × 3 days
11. Inj. Methylcobalamin (Optinerve) in 100ml NS IV OD

Drug Interactions

⚠️ Significant Interactions

Summary of Most Critical Interactions

1. Meropenem + Amikacin — Risk of nephrotoxicity (most important); do NOT co-infuse in same line
2. Ondansetron + Doxycycline — QTc prolongation risk; obtain baseline ECG
3. Doxycycline absorption — Reduced by cations; administer on empty stomach, separate from other drugs

Non-Pharmacological Management

For UTI

• Increase oral fluid intake to ≥2–3 litres/day to promote urinary flushing and reduce bacterial colonization
• Frequent and complete voiding — do not hold urine; void after intercourse if applicable
• Perineal hygiene — front-to-back wiping; avoid harsh soaps/douches
• Avoid urinary catheterization unless essential; if catheterized, strict aseptic technique and early removal
• Warm sitz baths for dysuria/perineal discomfort
• Adequate rest and avoidance of strenuous activity during acute phase
• Cranberry products — some evidence for prophylaxis (reduces bacterial adhesion); not a treatment substitute

For Normocytic Normochromic Anaemia

• Dietary counselling — balanced diet rich in protein, iron, folate, B12
• Treat underlying cause — in this case, likely anaemia of chronic infection/inflammation; resolves as infection is treated
• Avoid NSAIDs (which can cause gastric blood loss) — paracetamol is correctly being used here
• Transfusion only if Hb <7 g/dL or symptomatic (haemodynamic instability)

For Eosinophilia (likely parasitic — hence Albendazole prescribed)

• Sanitation measures — clean water, proper cooking of food, footwear outdoors (to prevent soil-transmitted helminths)
• Hand hygiene before eating, after defecation
• Deworming of close contacts/family members if intestinal helminths confirmed
• Nutritional support — high-protein diet to counter protein-losing enteropathy from helminths
• Avoid raw/undercooked meat and unwashed vegetables

General Supportive Measures

• Monitor vital signs (BP, HR, temperature, SpO₂) — patient is on IV antibiotics suggesting moderate-to-severe infection
• Daily monitoring of renal function (creatinine, urea) given meropenem + amikacin combination
• IV fluid management: current regimen of 150ml/hr — reassess to avoid fluid overload
• Oral hygiene maintenance during antibiotic therapy (to prevent oral candidiasis)
• Mobilization as tolerated to prevent DVT during hospital stay
• Nutritional support — high calorie, high protein diet

Key clinical alert: The meropenem + amikacin combination is a powerful broad-spectrum regimen appropriate for severe UTI but carries significant nephrotoxicity risk. Daily renal function tests and amikacin level monitoring are essential.

Patient Summary

Medications Identified (Full List)

Drug Interactions

⚠️ Significant / Critical Interactions

Summary of Most Critical Interactions

1. 🔴 Enalapril + ARB (Dual RAAS) — Contraindicated in AKI; highest priority to resolve
2. 🔴 Atenolol + Deriphylline — Antagonistic; compromises respiratory treatment
3. 🟠 Shellcal + Levothyroxine — Reduced thyroid hormone absorption; separate timing
4. 🟠 Duplicate Pantoprazole (IV + oral) — Rationalise to single route
5. 🟠 Duplicate Budesonide nebulisation — Same drug prescribed twice

Non-Pharmacological Management

For UTI

• Increase fluid intake to ≥2–3 L/day (unless restricted due to AKI)
• Frequent and complete voiding; avoid bladder retention
• Perineal hygiene — front-to-back wiping; avoid scented products
• Avoid urinary catheterization unless essential
• Monitor urine output and colour daily

For AKI (Acute Kidney Injury — under evaluation)

• Strict fluid balance — monitor input/output chart; target adequate hydration
• Avoid nephrotoxic drugs — review and stop any NSAIDs immediately (given history of chronic NSAID use)
• Diet: Low potassium, low phosphate, controlled protein during acute phase
• Daily weight monitoring to detect fluid retention
• Avoid contrast agents and other nephrotoxins
• Withhold ACE inhibitor/ARB if AKI is worsening (already flagged above)

For Arthralgia / Joint Pains + Proximal Muscle Pain

• Physiotherapy — already prescribed ✓ (proximal muscle strengthening)
• Hot/cold packs for acute joint pain relief
• Rest and activity modification — avoid high-impact activities
• Gentle range-of-motion exercises to maintain joint mobility
• Weight management (reduces load on joints; relevant given DM and HTN)
• Ergonomic support — appropriate footwear, knee bracing if needed for left knee trauma

For Diabetes (GRBS 260 — poorly controlled)

• Diet counselling — low glycaemic index diet; avoid refined carbohydrates and sugary foods
• Regular meal timing — prevents glucose spikes and hypoglycaemia on insulin
• Daily blood glucose monitoring (sliding scale in place ✓)
• Physical activity — gentle walking as tolerated (improves insulin sensitivity)
• Foot care — daily inspection, avoid barefoot walking

For Hypertension

• Salt restriction (<2g sodium/day)
• DASH diet — fruits, vegetables, low-fat dairy
• Avoid stress; adequate sleep
• Regular BP monitoring (both arms)
• Alcohol and smoking avoidance (addictions absent — good ✓)

For Hypothyroidism

• Take levothyroxine 30–60 minutes before breakfast on an empty stomach
• Separate from calcium, iron, antacids by at least 4 hours
• Regular thyroid function monitoring (TSH, T3, T4)
• Report symptoms of under-treatment (fatigue, cold intolerance, constipation) or over-treatment (palpitations, tremor)

General Supportive Measures

• Nutritional support — adequate protein, vitamins (Nephro Saue and Evion LC already prescribed ✓)
• Patient education about polypharmacy risks and the importance of not self-medicating with OTC steroids or analgesics
• Stress management and psychological support — multiple chronic conditions can cause anxiety
• Regular follow-up for all three chronic conditions (DM, HTN, Hypothyroidism)

Key nursing alerts: Monitor BP and HR closely given dual antihypertensive + AKI; check GRBS before each insulin dose; ensure levothyroxine is given separately from calcium; rationalise duplicate pantoprazole and budesonide with the treating physician.

Clinical Case Analysis — Naseem Begum

STEP 1 — Building the Problem List

STEP 2 — Pathophysiological Reasoning

Why does this patient likely have AKI?

• Prerenal: HTN on multiple antihypertensives (Enalapril + ARB + Amlodipine + Atenolol) → potential hypoperfusion; poor oral intake (decreased appetite noted)
• Intrinsic — ATN: Chronic NSAID use reduces prostaglandin-mediated afferent arteriolar dilation → reduced GFR → ischaemic ATN
• Intrinsic — Interstitial: Chronic NSAID/steroid use → analgesic nephropathy
• Aggravated by: ACE inhibitor (Enalapril) + ARB (Telmisartan) dual blockade → efferent arteriole dilation → further drops GFR

PG key point: In a patient with DM + HTN + chronic NSAID use, the most likely AKI mechanism is haemodynamic (NSAID + dual RAAS blockade) superimposed on chronic analgesic nephropathy.

Why does this patient have multiple joint pains?

Most likely: Combination of hypothyroid arthropathy + steroid-induced proximal myopathy — the physiotherapy prescribed for "proximal muscles" strongly hints at this.

STEP 3 — Investigations to Order (What a PG Should Know)

For AKI Workup

For Joint Pain Workup

For Diabetes

STEP 4 — KDIGO AKI Staging (Know This)

This patient needs staging once creatinine is reported.

STEP 5 — Prescribing Pitfalls in This Case (PG-Level Critique)

• She has respiratory symptoms (on budesonide + deriphylline) → atenolol can precipitate bronchospasm
• She is on insulin → atenolol masks hypoglycaemic tachycardia
• For HTN in DM + CKD: ACE inhibitor alone or ARB alone is the preferred choice (not both, and not beta-blocker first line)
• If a beta-blocker is needed: prefer metoprolol or bisoprolol (cardioselective)

• Impairs neutrophil function → increases UTI susceptibility
• Causes osmotic diuresis → dehydration → worsens AKI
• Promotes glycosuria → bacterial growth medium in urine

STEP 6 — Self-Assessment Questions

1. What is the most likely cause of AKI in this patient? (Think: NSAID + dual RAAS + DM)
2. What urine cast would you expect if this is ATN? (Muddy brown granular casts)
3. What is FENa and how do you calculate it? (FENa = (UNa × PCr) / (PNa × UCr) × 100)
4. Why is budesonide being prescribed twice? What would you do? (Duplicate — consolidate to one)
5. Which drug here should be stopped first given AKI? (NSAIDs from history; then rationalise dual RAAS)
6. What is the mechanism of steroid-induced proximal myopathy? (Type II fibre atrophy, mitochondrial dysfunction, protein catabolism)
7. Why is ceftriaxone appropriate for this UTI rather than oral antibiotics? (Likely complicated UTI — AKI, DM, possible urosepsis)
8. What are the KDIGO criteria for AKI? (See Step 4 above)

STEP 7 — Key Learning Points Summary